Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
07/2007
07/11/2007EP1448397B1 Heat-sensitive recording material
07/11/2007CN1997638A 1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP1-B inhibitors
07/11/2007CN1997626A Inhibitors of histone deacetylase
07/11/2007CN1326153C Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells
07/10/2007US7241810 For therapy of inflammatory, allergic and respiratory diseases
07/05/2007WO2007076306A1 Fluorinated compounds
07/05/2007WO2007074553A1 CATALYST CAPABLE OF ALLOWING STRECKER REACTION TO PROCEED STEREOSELECTIVELY AND METHOD FOR STEREOSELECTIVELY PRODUCING α-AMINONITRILE DERIVATIVE USING THE SAME
07/05/2007US20070155989 Trifluoroacetate blocking of alanine amino group, friedel crafts reaction with methoxybenzene, reduction of carbonyl group, chlorosulphonation and deprotection; claimed tamsulosin intermediates; simplification
07/05/2007US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
07/05/2007US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS
07/05/2007US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
07/05/2007US20070155748 N-sulfonyl-alpha-amino-acid derivatives
07/05/2007US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
07/05/2007US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007CA2623250A1 Fluorinated compounds
07/04/2007EP1803706A1 HIV protease inhibitors based on amino acid derivatives
07/04/2007EP1803453A1 Carbamate antibiotics
07/04/2007CN1993117A Hydroxy alkylamide compound
07/04/2007CN1324012C TNF-alpha prodn. inhibitors
07/04/2007CN1324006C Beta-amino acid nitrile derivs.
07/03/2007US7238839 Mixing R(-)-1,1'-binaphthyl-2,2'-diyl-hydrogen phosphate and tamsulosin in an organic solvent to form a solid R-tamsulosin-S-BPA salt, filtering, basifiying, isolating the solid R-tamsulosin free base by extraction, converting the R-tamsulosin free base to a pharmaceutically acceptable salt
07/03/2007US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
07/03/2007CA2278798C Aminobenzophenones as inhibitors of interleukin and tnf
07/03/2007CA2219655C Process for the catalytic hydrogenation of aromatic nitro compounds
06/2007
06/28/2007WO2007073168A1 Carbamate antibiotics
06/28/2007WO2007071638A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor
06/28/2007WO2007071443A1 Inhibitors of ccr9 activity
06/28/2007WO2007071441A1 Inhibitors of ccr9 activity
06/28/2007WO2007039125A3 An optically active thyroid receptor agonist and optically active key intermediates in its production
06/28/2007US20070149831 1,2-di(4-N,N-dimethylaminophenyl)ethylene-1,2-diamine catalyst complex for asymmetric synthesis; for producing an optically active alcohol using the catalyst to asymmetrically reduce a ketone
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007CA2631816A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor
06/28/2007CA2631436A1 Inhibitors of ccr9 activity
06/28/2007CA2631432A1 Inhibitors of ccr9 activity
06/27/2007EP1799665A1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid
06/27/2007EP1799637A1 Substituted sulfonamidopropionamides and methods of use
06/27/2007EP1799636A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
06/27/2007EP1272459B1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
06/27/2007CN1986525A 4-methoxy-1,3-phenyl disulfamide derivative and its application
06/26/2007US7235690 Anthranilamides and methods of their use
06/26/2007CA2155014C Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups
06/26/2007CA2142309C Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric
06/21/2007WO2007047447A3 Diuretic-like compound analogs useful for regulation of central nervous system disorders
06/21/2007US20070142669 reacting o-ethoxyphenoxyethanol with sulfonyl chloride; reacting the sulfonate with (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide by condensation to produce Tamsulosin
06/21/2007US20070142471 Sulfonamides
06/21/2007US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142230 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants
06/20/2007EP1797083A1 Sulfonamide compounds
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007CN1984883A Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
06/20/2007CN1984880A Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient
06/19/2007US7232930 Compounds and methods for preparing methanesulfonamides
06/19/2007US7232929 Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
06/19/2007US7232927 Preparation of mono-N-sulphonylated diamines
06/19/2007US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
06/19/2007CA2221014C New family of monomeric or polymeric photoinitiators in which sulfonic groups are fso2 groups
06/14/2007WO2007067817A1 Abca1 elevating compounds
06/14/2007US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
06/14/2007US20070135490 Phenetanolamine derivatives
06/14/2007US20070135475 Process for the preparation of ccr-2 antagonists
06/13/2007EP1796193A1 Proton conductor and fuel cell using the same
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980892A Dpp-IV inhibitors
06/13/2007CN1321101C New retinoids for the treatment of emphysema
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/07/2007WO2007063028A2 Method for producing sulfonamides
06/07/2007WO2007043274A9 Polyarylene and process for producing the same
06/07/2007WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
06/07/2007US20070129422 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
06/07/2007US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors
06/07/2007US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester
06/07/2007US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia
06/07/2007CA2631113A1 Method for producing sulfonamides
06/06/2007EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents
06/06/2007EP1791809A1 Substituted aniline derivatives
06/06/2007CN1319941C Preparation of mono-N-sulfonicacid diamine
06/05/2007US7226578 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis
05/2007
05/31/2007WO2007060220A2 Cyanobenzene compounds for combating animal pests
05/31/2007WO2007060215A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
05/31/2007US20070123706 Method for producing 3-amidinophenylalanine derivatives
05/31/2007US20070123512 Propionamide derivatives useful as androgen receptor modulators
05/31/2007US20070122367 Resorcinol derivatives
05/31/2007CA2629935A1 (r)-arylalkylamino derivatives and pharmaceutical compositions containing them
05/30/2007EP1789409A2 Sulfonamides and uses thereof
05/30/2007EP1789381A2 Inhibitors of histone deacetylase
05/30/2007EP1476422B1 Method for treating an imide organic solution bearing a sulphonyl group
05/30/2007EP1177168B1 Caspase inhibitors and the use thereof
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1318412C Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
05/30/2007CN1318398C Perfluorovinyl ether monomer having sulfonamide group
05/29/2007US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
05/29/2007US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
05/24/2007WO2007058960A1 Sulfamoyl benzamides as cannabinoid receptor modulators
05/24/2007WO2007058639A2 Antibacterial agents
05/24/2007WO2007024860A3 Sulfonamides
05/24/2007US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis
05/24/2007US20070117803 Cyclohexyl-1,4-diamine compounds
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 177